Press Releases
Search
-
12 Jun 2018
NEPHROCHECK® Biomarkers TIMP-2 and IGFBP7 Included in Acute Dialysis Quality Initiative Recommendations
The biomarkers in the NEPHROCHECK® test, an FDA-cleared and CE-marked urine test that indicates kidney stress in advance of acute kidney injury (AKI), have been included in a second set of consensus r...
-
31 May 2018
bioMérieux launches ENDOZYME® II GO, an innovative test for the detection of endotoxins in pharmaceutical microbiology control
bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of ENDOZYME® II GO, a new endotoxin test in the bioMérieux ENDONEXTTM range of recombinant horseshoe...
-
02 May 2018
NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in Groundbreaking Consensus Statement of Best Practices to Enhance Recovery after Heart Surgery
Marcy l’Étoile (France) and San Diego (California) - May 2nd, 2018 – The biomarkers in the NEPHROCHECK test, an FDA-cleared and CE-marked urine test that indicates kidney stress in advance of acute ki...
-
23 Apr 2018
bioMérieux and the University of Antwerp award scholarships to three healthcare professionals for their commitment to improve antibiotic use in order to combat antimicrobial resistance
Marcy l'Étoile (France) – Antwerp (Belgium) – April 23, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, and the Laboratory of Medical Microbiology at the University of Antwerp ...
-
19 Apr 2018
bioMérieux submits for FDA Clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel
bioMérieux, a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510(k) clear...
-
19 Apr 2018
bioMérieux – First-Quarter 2018 Business Review
Strong sales dynamic in first-quarter 2018, with sales up 12.5% at constant exchange rates and scope of consolidation: €587 million in sales Up 3.4% as reported Growth driven by molecular biology in t...